Characterization of recombinant integrase of human immunodeficiency virus type 1 (isolate Bru)

被引:2
作者
Semenova, EA [1 ]
Gashnikova, NM [1 ]
Il'ina, TV [1 ]
Pronyaeva, TR [1 ]
Pokrovsky, AG [1 ]
机构
[1] State Res Ctr Virol & Biotechnol Vector, Inst Mol Biol, Koltsov 630559, Novosibirsk Reg, Russia
基金
俄罗斯基础研究基金会;
关键词
integrase; human immunodeficiency virus type 1; isolate Bru; aurintricarbonic acid;
D O I
10.1023/A:1026060512380
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Integration of the human immunodeficiency virus type 1 (HIV-1) DNA into the human genome requires the virus-encoded integrase protein. The recombinant integrase protein of HW-1 (isolate Bru) was prepared by constructing a plasmid based on pET-15b encoding the integrase gene. Integrase of HfV-1 was purified using a bacterial expression system (Escherichia coli). The main kinetic parameters of HIV-1 integrase (K-m = (3.7 +/- 0.2).10(-10) M, k(cat) = (1.2 +/- 0.3).10(-7) sec(-1)) were determined using an oligonucleotide duplex constructed on the basis of the U5-terminal sequence of proviral HIV-1 DNA as the substrate. Inhibition of integrase by aurintricarbonic acid ([I](50) = 6.3 +/- 0.4 muM) and dependence of integrase activity on Mg2+ and Mn2+ concentration were studied.
引用
收藏
页码:988 / 993
页数:6
相关论文
共 50 条
  • [31] Selective-Advantage Profile of Human Immunodeficiency Virus Type 1 Integrase Mutants Explains In Vivo Evolution of Raltegravir Resistance Genotypes
    Quercia, Romina
    Dam, Elisabeth
    Perez-Bercoff, Danielle
    Clavel, Francois
    JOURNAL OF VIROLOGY, 2009, 83 (19) : 10245 - 10249
  • [32] Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies
    Canducci, Filippo
    Sampaolo, Michela
    Marinozzi, Maria Chiara
    Boeri, Enzo
    Spagnuolo, Vincenzo
    Galli, Andrea
    Castagna, Antonella
    Lazzarin, Adriano
    Clementi, Massimo
    Gianotti, Nicola
    AIDS, 2009, 23 (04) : 455 - 460
  • [33] Mutagenesis of Lysines 156 and 159 in Human Immunodeficiency Virus Type 1 Integrase (IN) Reveals Differential Interactions between these Residues and Different IN Inhibitors
    Crosby, David C.
    Lei, Xiangyang
    Gibbs, Charles G.
    Reinecke, Manfred G.
    Robinson, W. Edward, Jr.
    NATURAL PRODUCT COMMUNICATIONS, 2015, 10 (01) : 117 - 124
  • [34] Beauvericin and enniatins H, I and MK1688 are new potent inhibitors of human immunodeficiency virus type-1 integrase
    Shin, Cha-Gyun
    An, Dog-Gn
    Song, Hyuk-Hwan
    Lee, Chan
    JOURNAL OF ANTIBIOTICS, 2009, 62 (12) : 687 - 690
  • [35] Evaluation of selected South African medicinal plants for inhibitory properties against human immunodeficiency virus type 1 reverse transcriptase and integrase
    Bessong, PO
    Obi, CL
    Andréola, ML
    Rojas, LB
    Pouységu, L
    Igumbor, E
    Meyer, JJM
    Quideau, S
    Litvak, S
    JOURNAL OF ETHNOPHARMACOLOGY, 2005, 99 (01) : 83 - 91
  • [36] Resistance to inhibitors of the human immunodeficiency virus type 1 integration
    Hazuda, Daria J.
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2010, 14 (05) : 513 - 518
  • [37] Human Immunodeficiency Virus Type 1 Employs the Cellular Dynein Light Chain 1 Protein for Reverse Transcription through Interaction with Its Integrase Protein
    Jayappa, Kallesh Danappa
    Ao, Zhujun
    Wang, Xiaoxia
    Mouland, Andrew J.
    Shekhar, Sudhanshu
    Yang, Xi
    Yao, Xiaojian
    JOURNAL OF VIROLOGY, 2015, 89 (07) : 3497 - 3511
  • [38] Human Immunodeficiency Virus Integrase Pharmacophore Model Derived from Diketoacids Inhibitors
    Zhang Xiao-Yi
    Liu Bin
    He Hong-Qiu
    Yang Dong
    Wang Cun-Xin
    ACTA PHYSICO-CHIMICA SINICA, 2009, 25 (05) : 817 - 824
  • [39] Isolation of two highly potent and non-toxic inhibitors of human immunodeficiency virus type 1 (HIV-1) integrase from Salvia miltiorrhiza
    Abd-Elazem, IS
    Chen, HS
    Bates, RB
    Huang, RCC
    ANTIVIRAL RESEARCH, 2002, 55 (01) : 91 - 106
  • [40] A New Mechanism of Resistance of Human Immunodeficiency Virus Type 2 to Integrase Inhibitors: A 5-Amino-Acid Insertion in the Integrase C-Terminal Domain
    Le Hingrat, Quentin
    Collin, Gilles
    Le, Minh
    Peytavin, Gilles
    Visseaux, Benoit
    Bertine, Melanie
    Tubiana, Roland
    Karmochkine, Marina
    Valin, Nadia
    Collin, Fideline
    Lemaignen, Adrien
    Bernard, Louis
    Damond, Florence
    Matheron, Sophie
    Descamps, Diane
    Charpentier, Charlotte
    Meyohas, Pr
    Salmon, Pr
    Pialoux, Pr
    Matheron, Pr
    Tubiana, Dr
    De Truchis, Dr
    Khuong-Josses
    Goujard, Pr
    Gerard, Dr
    Mortier, Dr
    Welker, Dr
    Daneluzzi, Dr
    Genet, Dr
    Lepretre, Dr
    Zucman, Dr
    Force, Dr
    Coutellier-Simon, Dr
    Deleuze, Dr
    Weiss, Pr
    Garrait, Dr
    Colin, Dr Masson
    Lelievre, Pr
    Blum, Dr
    Dulioust, Dr
    Perrone, Dr
    Winter, Dr
    La Torre, Dr
    Molina, Pr
    Devidas, Dr
    Brunet, Dr
    Rouveix, Pr
    Kernbaum, Dr
    Duvivier, Dr
    Bouldouyre, Dr
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (04) : 657 - 667